Matinas BioPharma Holdings, Inc.
MTNB
$0.62
$0.0294.91%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -58.69% | 29.40% | 5.63% | -5.64% | -46.23% |
| Total Depreciation and Amortization | 2.92% | 2.52% | 2.99% | 4.80% | 6.19% |
| Total Amortization of Deferred Charges | -115.89% | -- | 59.09% | -59.09% | 101.89% |
| Total Other Non-Cash Items | 289.43% | -20.20% | -24.12% | -21.78% | -11.85% |
| Change in Net Operating Assets | 110.82% | -336.22% | -40.82% | -906.72% | 65.22% |
| Cash from Operations | 23.35% | 20.80% | -41.63% | -41.15% | -6.51% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -83.11% | 776.91% | -145.91% | -33.33% | -- |
| Cash from Investing | -83.11% | 789.85% | -147.40% | -33.33% | 7,147.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -100.00% | 0.00% | 75.00% | 80.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | -6,600.00% | 919,000.00% | 1,425.00% | 80.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -85.86% | 282.22% | -21.45% | -240.60% | 62.72% |